Register entry
- Registered sites
- 1
- Active NDC listings
- 8
- Live patents
- 152
- Exclusivities
- 2
- Shortage listings
- 1
- Countries
- 1
- Base
- United States
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | 6027 Edgewood Bend Ct., San Diego, California (CA) 92130-8235, United States (USA) | Finished drug manufacture | 1000202524800981276 |
Alert
Drug shortage listings
1| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Crinecerfont CapsuleEndocrinology/Metabolism | Crenessity, Capsule, 25 mg (NDC 70370-5025-1) | To Be Discontinued | - | 28 Apr 202628 Apr 2026 |
Catalogue
Drug listings by form and route
88 active NDC listings: 8 human prescription drug. By marketing category: NDA 8.
| Dosage form | NDCs |
|---|---|
| capsule | 6 |
| kit | 2 |
| Route | NDCs |
|---|---|
| oral | 8 |
| Labeller name on the listing | NDCs |
|---|---|
| neurocrine biosciences, inc. | 8 |
Exclusivity
Patents and exclusivities
152| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8357697 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | use | Nov 2027 |
| 8039627 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | substance, product | Apr 2031 |
| 10905690 | CRENESSITYcrinecerfont | use | Jan 2035 |
| 11311544 | CRENESSITYcrinecerfont | use | Jan 2035 |
| 11730739 | CRENESSITYcrinecerfont | use | Jan 2035 |
| 10065952 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | substance, product | Oct 2036 |
| 10844058 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | substance, product | Oct 2036 |
| 10851103 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | substance, product | Oct 2036 |
| 10851104 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | substance | Oct 2036 |
| 10906902 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | substance, product | Dec 2036 |
| 10906903 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | substance, product | Dec 2036 |
| 10919892 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | substance, product | Dec 2036 |
| 10857137 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | use | Oct 2037 |
| 10857148 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | use | Oct 2037 |
| 10874648 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | use | Oct 2037 |
| 10912771 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | use | Oct 2037 |
| 10952997 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | use | Oct 2037 |
| 10993941 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | use | Oct 2037 |
| 11040029 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | use | Oct 2037 |
| 11439629 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | use | Oct 2037 |
| 11026939 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | product | Sept 2038 |
| 11311532 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | product | Sept 2038 |
| 11654142 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | use | Nov 2038 |
| 11026931 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | use | Aug 2039 |
| 10940141 | INGREZZA, INGREZZA SPRINKLEvalbenazine tosylate | use | Aug 2040 |
| 12128033 | CRENESSITYcrinecerfont | substance | Jun 2041 |
| 12582634 | CRENESSITYcrinecerfont | substance | Jan 2043 |
| Product | Exclusivity | Until |
|---|---|---|
| CRENESSITYCRINECERFONT | ODE-503 Orphan drug | Dec 2031 |
| INGREZZAVALBENAZINE TOSYLATE | ODE-440 Orphan drug | Aug 2030 |
Catalogue
Marketed products
8| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| INGREZZA | Valbenazine | capsule, oral | 70370-1060NDA |
| INGREZZA | Valbenazine | capsule, oral | 70370-1080NDA |
| INGREZZA | Valbenazine | capsule, oral | 70370-2040NDA |
| INGREZZA | Valbenazine | kit, oral | 70370-2046NDA |
| INGREZZA | Valbenazine | kit, oral | 70370-2048NDA |
| INGREZZA Sprinkle | Valbenazine | capsule, oral | 70370-4040NDA |
| INGREZZA Sprinkle | Valbenazine | capsule, oral | 70370-4060NDA |
| INGREZZA Sprinkle | Valbenazine | capsule, oral | 70370-4080NDA |
Neighbours
Registered in the same town
12- PCI Pharma Services Canada, Inc.San Diego, CA · 3 sites
- Nielsen BioSciences, Inc.San Diego, CA · 2 sites
- PETNET Solutions, Inc.San Diego, CA
- Synergy Health AST, LLCSan Diego, CA
- STA Pharmaceutical US LLCSan Diego, CA
- Wacker Biotech GmbHSan Diego, CA
- Infinity Labs, SD Inc.San Diego, CA
- SOHM, Inc.San Diego, CA
- Verio Healthcare, Inc.San Diego, CA
- Allermed Laboratories, Inc.San Diego, CA
- CA-BOTANA INTERNATIONALSAN DIEGO, CA
- King Tech Industry, Inc.San Diego, CA
Compare
Comparable companies in United States
- Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals1 site · 4,853 NDC
- NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
- Greer Laboratories, Inc.1 site · 1,328 NDC
- ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Rising Pharma Holdings, Inc.1 site · 532 NDC
- HF Acquisition Co LLC1 site · 363 NDC
- ANI Pharmaceuticals, Inc.1 site · 299 NDC
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
- Newton Laboratories, Inc.1 site · 271 NDC
Enquiry
Common questions
- Is Neurocrine Biosciences, Inc. FDA approved?
- Neurocrine Biosciences, Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Neurocrine Biosciences, Inc.'s drugs manufactured?
- The FDA register lists San Diego, CA. Registered operations: finished drug manufacture.
- What drugs does Neurocrine Biosciences, Inc. make?
- 8 products are listed under Neurocrine Biosciences, Inc. in the openFDA NDC Directory, most often as capsule; kit. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.